Author： Sweet D.G. Halliday H.L.
Publisher： Adis International
ISSN： 0114-5916
Source： Drug Safety, Vol.22, Iss.5, 2000-05, pp. : 389-404
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Risk-Benefit Assessment of Opioids in Chronic Noncancer Pain
By Bannwarth B.
Drug Safety, Vol. 21, Iss. 4, 1999-10 ,pp. :
Access to resources
Recommend
A Risk-Benefit Assessment of the Newer Oral Antifungal Agents Used to Treat Onychomycosis
By Gupta A.K.
Drug Safety, Vol. 22, Iss. 1, 2000-01 ,pp. :
A Risk-Benefit Assessment of Abciximab in Angioplasty
By Kleiman N.S.
Drug Safety, Vol. 20, Iss. 1, 1999-01 ,pp. :
A Risk-Benefit Assessment of Amifostine in Cytoprotection
By Mabro M.
Drug Safety, Vol. 21, Iss. 5, 1999-11 ,pp. :